In that sense, and although no studies on MAGI2-AS3 in AD patients have been reported yet, MAGI2-AS3 appears in a screening of the ceRNA network in human asthma studies [93], confirming a potential pro-inflammatory role of MAGI2-AS3. This evidence concerns the gene PDS5B and asthma.